Takashi Kumano

Development of ET, primary myelofibrosis and PV in mice expressing JAK2 V617F

Kotaro Shide, Haruko Shimoda, Takashi Kumano et al. · Leukemia · 2007 · 168 citations

Inflammation, Cytokine, Hematological Malignancy +12

JAK2 V617F uses distinct signalling pathways to induce cell proliferation and neutrophil activation

Seido Oku, Katsuto Takenaka, Takuro Kuriyama et al. · British Journal of Haematology · 2010 · 50 citations · Full text

Distinctive expression of myelomonocytic markers and down‐regulation of CD34 in acute myelogenous leukaemia with FLT3 tandem duplication and nucleophosmin mutation

Yasuo Mori, Goichi Yoshimoto, Takashi Kumano et al. · European Journal Of Haematology · 2007 · 27 citations

Tyk2 mutation homologous to V617F Jak2 is not found in essential thrombocythaemia, although it induces constitutive signaling and growth factor independence

Kotaro Shide, Kazuya Shimoda, Kenjirou Kamezaki et al. · Leukemia Research · 2006 · 13 citations

Thrombopoiesis, Thrombosis, V617f Jak2 +13

Rapid Progression of Vascular and Soft Tissue Calcification while Being Managed for Severe and Persistent Hypocalcemia Induced by Denosumab Treatment in a Patient with Multiple Myeloma and Chronic Kidney Disease

Kenji Ueki, Shunsuke Yamada, Akihiro Tsuchimoto et al. · Internal Medicine · 2015 · 13 citations · Full text

Electrolyte Disorder, Urology, Renal Function +11